Respiratory Research (Jul 2018)

Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD

  • Nicholas P. Williams,
  • Kristoffer Ostridge,
  • Jeanne-Marie Devaster,
  • Viktoriya Kim,
  • Ngaire A. Coombs,
  • Simon Bourne,
  • Stuart C. Clarke,
  • Stephen Harden,
  • Ausami Abbas,
  • Emmanuel Aris,
  • Christophe Lambert,
  • Andrew Tuck,
  • Anthony Williams,
  • Stephen Wootton,
  • Karl J. Staples,
  • Tom M. A. Wilkinson,
  • on behalf of the AERIS Study Group

DOI
https://doi.org/10.1186/s12931-018-0842-8
Journal volume & issue
Vol. 19, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Background COPD patients have increased risk of developing pneumonia, which is associated with poor outcomes. It can be symptomatically indistinguishable from exacerbations, making diagnosis challenging. Studies of pneumonia in COPD have focused on hospitalised patients and are not representative of the ambulant COPD population. Therefore, we sought to determine the incidence and aetiology of acute exacerbation events with evidence of pneumonic radiographic infiltrates in an outpatient COPD cohort. Methods One hundred twenty-seven patients with moderate to very severe COPD aged 42–85 years underwent blood and sputum sampling over one year, at monthly stable visits and within 72 h of exacerbation symptom onset. 343 exacerbations with chest radiographs were included. Results 20.1% of exacerbations had pneumonic infiltrates. Presence of infiltrate was highly seasonal (Winter vs summer OR 3.056, p = 0.027). In paired analyses these exacerbation events had greater increases in systemic inflammation. Bacterial detection rate was higher in the pneumonic group, with Haemophilus influenzae the most common bacteria in both radiological groups. Viral detection and sputum microbiota did not differ with chest radiograph appearance. Conclusions In an outpatient COPD cohort, pneumonic infiltrates at exacerbation were common, and associated with more intense inflammation. Bacterial pathogen detection and lung microbiota were not distinct, suggesting that exacerbations and pneumonia in COPD share common infectious triggers and represent a continuum of severity rather than distinct aetiological events. Trial registration Trial registration Number: NCT01360398.

Keywords